Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
10.82%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 2.12Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information
Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINMED PHARMACEUTICALS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INM - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 534.72K | 10.82% | $ 4.94M |
| 3/31/2025 | $ 555.5K | 11.29% | $ 4.92M |
| 12/31/2024 | $ 576.61K | 11.93% | $ 4.83M |
| 9/30/2024 | $ 600.13K | 12.1% | $ 4.96M |
| 6/30/2024 | $ 604.52K | 13.15% | $ 4.6M |
| 3/31/2024 | $ 603.63K | 10.73% | $ 5.63M |
| 12/31/2023 | $ 602.11K | 10.97% | $ 5.49M |
| 9/30/2023 | $ 596.85K | 12.65% | $ 4.72M |
| 6/30/2023 | $ 596K | 14.41% | $ 4.14M |
| 3/31/2023 | $ 599.09K | 25.61% | $ 2.34M |
Key Performance Insights, Last 5 Years
- INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) DepAmor % stands at 0%.
- Over the past 5 years, INMED PHARMACEUTICALS INC's average DepAmor % has been 29.83%.
- The median DepAmor % for INMED PHARMACEUTICALS INC during this period was 13.15%
- INMED PHARMACEUTICALS INC reached its highest DepAmor % over the past 5 years at 115.9%.
- The lowest DepAmor % recorded by INMED PHARMACEUTICALS INC in the same timeframe 10.73%
INMED PHARMACEUTICALS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for INMED PHARMACEUTICALS INC is calculated as follows: DepAmor [ $ 228.69K ] / Revenues [ $ 0 ]
(=) DepAmor % [ 0% ] INM - Depreciation and Amortization Margin, Last 5 years
10.73%
Minimum
Mar 31, 2024
115.9%
Maximum
Dec 31, 2021
29.83%
Average
13.15%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |